INO (STOCKS)
Inovio Pharmaceuticals, Inc.
$1.570000
-0.040000 (-2.48%)
Prev close: $1.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jacqueline E. Shea
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $109.10M
- Employees
- 134
- P/E (TTM)
- -0.62
- P/B (TTM)
- -11.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.87 | $-0.43 | -0.4426 | -103.56% |
|
Jun 2025 (Q2)
|
$-0.61 | $-0.62 | +0.0053 | +0.86% |
|
Mar 2025 (Q1)
|
$-0.41 | $-0.75 | +0.3354 | +45.00% |
|
Dec 2024 (Q4)
|
$-0.60 | $-0.85 | +0.2454 | +29.03% |
Financial Statements
| Revenues | $182.34K |
| Benefits Costs and Expenses | $107.47M |
| Costs And Expenses | $84.75M |
| Operating Expenses | $89.90M |
| Research and Development | $56.83M |
| Other Operating Expenses | $33.07M |
| Operating Income/Loss | -$89.72M |
| Income/Loss From Continuing Operations After Tax | -$108.09M |
| Income/Loss From Continuing Operations Before Tax | -$107.29M |
| Net Income/Loss | -$108.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$108.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$108.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.72 |
| Diluted Earnings Per Share | -$2.72 |
| Basic Average Shares | 91,835,025 |
| Diluted Average Shares | 91,835,025 |
| Assets | $69.39M |
| Current Assets | $55.18M |
| Cash | $50.80M |
| Other Current Assets | $4.38M |
| Noncurrent Assets | $14.21M |
| Fixed Assets | $2.74M |
| Other Non-current Assets | $11.46M |
| Liabilities | $77.11M |
| Current Liabilities | $69.82M |
| Noncurrent Liabilities | $7.28M |
| Equity | -$7.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$7.72M |
| Liabilities And Equity | $69.39M |
| Net Cash Flow From Operating Activities | -$88.92M |
| Net Cash Flow From Operating Activities, Continuing | -$88.92M |
| Net Cash Flow From Investing Activities | $48.74M |
| Net Cash Flow From Investing Activities, Continuing | $48.74M |
| Net Cash Flow From Financing Activities | $55.06M |
| Net Cash Flow From Financing Activities, Continuing | $55.06M |
| Exchange Gains/Losses | $0.00 |
| Net Cash Flow | $14.88M |
| Net Cash Flow, Continuing | $14.88M |
| Comprehensive Income/Loss | -$108.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$108.12M |
| Other Comprehensive Income/Loss | -$108.12M |